NCT07737314
Tele-HOPE: A Telehealth Pharmacist Opioid Patient Education Pilot Study
StatusRecruiting
PhaseNot applicable
Primary completion (estimated)
Track this trial
Free. We email you which fields changed when ClinicalTrials.gov updates this record.
Record History
All 3 versions: 3 with changes below. See every version on ClinicalTrials.gov ↗
- Notable Recruitment opened
- Start date changed from estimate of Nov 1, 2026 to Nov 3, 2026
- Site details revised
- Notable Eligibility criteria expanded, about 7 words
- Primary endpoints: details revised at 1 of 2 entries
- Site details revised
- Study First Submitted
- Notable: the plan changed
Endpoints
Primary
Percentage of referred patients who attend pharmacist education session (Feasibility)
Timeframe: Up to 6 months
Participant score on the "general acceptability" item of the Theoretical Framework of Acceptability questionnaire
Timeframe: Up to 1 month post-session
Arms and interventions
Supportive care (pharmacist-led opioid education session)Experimental
Patients scheduled to attend a pharmacist-led group telehealth opioid education session who enroll in the study will complete a survey before the session and another survey afterward. After attending the pharmacist education session, patients will receive a patient education handout summarizing the educational content.
Other: Survey Administration, Electronic Health Record Review
Sites
1 site in 1 country
- Fred Hutch/University of Washington Cancer ConsortiumSeattle, Washington, United States